D

PriceDaxor

DXR

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Historical stock price chart and annual return over the past years

-40%

5 years

% Total

DXR
-10%

5 years

Annual Return

DXR